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Abstract
Objective: To evaluate clinical and histological features of duodenal ulcer in children and adolescents.
Methods: Forty-three children with duodenal ulcer were prospectively and consecutively evaluated in a 6 year period
(7.2 patients per year). Evaluation included clinical questionnaire focused on dyspeptic symptoms, physical examination,
and digestive endoscopy with gastric biopsies for histological examination and Helicobacter pylori detection.
Results: Diagnostic age ranged from 4 years and 8 months to 17 years and 4 months (mean age: 12 years and 4
months). Abdominal pain was the main symptom (39/43, 90.7%), which was epigastric in 31/39, periumbilical in 7/39,
and nocturnal in 27/39. Other symptoms were loss of appetite (32/43, 74.4%), vomiting (30/43, 69.8%), postprandial
fullness (23/43, 53.5%), weight loss (22/43, 51.2%), and abdominal tenderness (19/43, 44.2%). Upper gastrointestinal
bleeding occurred in 19/43 (44.2%), whereas anemia occurred in (21/43, 48.8%). Helicobacter pylori infection was
detected in 41/43 (95.3%). All infected patients presented acute chronic gastritis in antrum, with lymphomononuclear
infiltrate predominance in 92% of them. Eradication of the bacterium occurred in 68.3%. Ulcer healing occurred in all
eradicated patients and in 89% of non-eradicated patients.
Conclusion: Duodenal ulcer was associated with chronic gastritis due to Helicobacter pylori in the majority of patients.
Many complications occurred, especially upper digestive bleeding.
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Chronic gastritis associated with Helicobacter pylori
infection is often observed in children with primary
duodenal ulcer, and there is common agreement that the
bacterium can be eradicated by the marked reduction in
the incidence of ulcer relapses.1 Colonization of the
gastric mucosa by Helicobacter pylori, a microaerophilic,
spiral-shaped Gram-negative bacillus, is currently
uncommon among children who live in industrialized
countries, compared to those who live in developing
countries, with a prevalence up to the tenth year of life of
5 to 10% and up to 80%, respectively.2 The major risk
factors for acquiring the infection are: living in a developing
country, being a child with infected parents, and low
family income.3 Most patients are asymptomatic, and
approximately 15% develop peptic ulcer and 1%, gastric
cancer.4 After gastritis is established, the bacterium
often persists throughout the patients life, and
spontaneous eradication is rare. There is no definitive
conclusion about the influence of bacterial virulence
factors, host response or environmental conditions on the
course of this disease.
The actual prevalence of duodenal ulcer among
pediatric patients remains unclear. Four to six new cases/
year are reported in large centers, but gastric ulcer is
seldom observed. In developing countries, dissimilar
prevalence rates for duodenal ulcer exist due to ethnic or
regional differences.5 The clinical symptoms of duodenal
ulcer often are atypical, but adolescents have symptoms
similar to those observed in adults.6
The aim of the present study is to assess clinical and
histological aspects of duodenal ulcer associated with
Helicobacter pylori infection in children and adolescents.
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Methods
A prospective study was carried out with 34 (79.1%)
patients with duodenal ulcer and nine (20.9%) patients with
erosive duodenitis (whose clinical course is the same as that
of duodenal ulcer) treated at the Division of Digestive
Endoscopy, Discipline of Pediatric Gastroenterology of
UNIFESP/EPM in a consecutive period of six years (mean of
7.2 cases/year). Patients who had been taking nonsteroidal
anti-inflammatory drugs or antibiotics for at least one
month before endoscopic examination and those with
other digestive or extradigestive diseases were not included
in the study.
Clinical assessment
A clinical questionnaire containing dyspeptic signs and
symptoms was applied. Patients themselves answered the
questions, but their answers were confirmed by their parents,
whenever necessary. When the answers were not clear or
when the answers given by patients and parents differed,
the information was left out of the analysis. The signs and
symptoms concerned the ones observed before endoscopic
examination, including abdominal pain (site: epigastric,
periumbilical, diffuse, other site; frequency; type of pain:
burning, colicky, sharp, feeling of hunger, undefined;
intensity: mild, moderate, intense; night pain; relationship
with food intake: relief, deterioration or no relation), vomiting,
nausea, weight loss, loss of appetite, family history,
abdominal sensitivity, postprandial fullness, upper
gastrointestinal bleeding, and anemia. Pain intensity was
related to interference with patients usual activities. Night
pain was defined as the kind of pain that awakens the patient
at night. Family history of peptic ulcer (first or second-
degree relative) was only considered when peptic ulcer was
confirmed by endoscopic examination. The nutritional status
was assessed using the body mass index.7
Helicobacter pylori detection
Four endoscopic biopsies were obtained from the antrum
within 2 cm of the pylorus for rapid urease test and
histological examination (HE and modified Giemsa). The
endoscope and the biopsy forceps were disinfected after
each procedure by means of intense manual cleaning with
an enzyme solution, immersion in a 2% glutaraldehyde
solution for 20 minutes and rinsing under running water.
The rapid urease test was prepared on the day of
endoscopic examination with an aqueous solution
containing urea at 10%, not commercially available, and
kept at room temperature.8 For histological analysis, the
specimens were placed on a filter paper, positioned and
fixed in 10% formaldehyde solution. The spiral-shaped
bacterium stained with modified Giemsa and hematoxylin-
eosin was detected in the gastric mucosal epithelial layer
or on the surface of epithelial cells. Inflammation of the
gastric mucosa was assessed according to the modified
Sydney system.9 Patients were considered to be infected
when the histological exam or rapid urease test yielded
positive results. H. pylori eradication after antimicrobial
therapy was checked using the same tests on gastric
biopsies obtained endoscopically two to three months
after the end of treatment.
Treatment for H. pylori infection
Treatments for the eradication of H. pylori were used
based on the protocol available at the time of diagnosis.
During this period, new treatments replaced those whose
eradication rate was not according to expectations. Double
or triple therapy containing colloidal bismuth subcitrate
(7-8 mg/kg/day in four doses) or proton pump inhibitor was
used in association with one or two of the following antibiotics:
amoxicillin (50 mg/kg/day in three doses); clarithromycin
(15 mg/kg/day in two doses); tetracycline (50 mg/kg/day
in three doses for children older than 10 years); nitroimidazole
derivatives, tinidazole (10-20 mg/kg/day in two doses) or
metronidazole (20 mg/kg/day in two doses); furazolidone
(7 mg/kg/day in two doses) for one to two weeks. In cases
of therapeutic failure, new antibiotic therapies were used,
replacing those which more frequently resulted in bacterial
resistance (clarithromycin and nitroimidazole derivatives)
or the length of treatment was extended from one to two
weeks. Three patients used colloidal bismuth subcitrate for
four to eight weeks combined with amoxicillin and
nitroimidazole derivative. H2 receptor antagonists (ranitidine
4-6 mg/kg/day, up to 150 mg in two doses, for six to eight
weeks) or proton pump inhibitors (omeprazole 0.7 mg/kg/day
up to 20 mg, for four weeks) followed antimicrobial therapy.
Statistical analysis
Quantitative variables were described as median and
variance, whereas qualitative variables were described as
sample proportion.10
The study protocol was approved by the Medical Ethics
Committee of UNIFESP- EPM.
Results
Age at the onset of symptoms in 43 patients ranged from
three years to 16 years and four months (median = 10 years
and nine months), whereas age at diagnosis ranged from
four years and eight months to 17 years and four months
(median = 12 years and four months). The diagnosis was
established in 72.1% (31/43) of the cases after the age of
10 years, and the male/female ratio was 1.65:1.
Clinical features are shown in Table 1. Ulcer complications
were observed in 48.8% of patients (21/43): upper
gastrointestinal bleeding affected 44.2% (19/43) and
gastroduodenal obstruction due to pyloric stenosis or
duodenal stenosis affected 4.7% (2/43) of the patients. In
most of the patients (16/19, 84.2%), gastric bleeding was
accompanied by abdominal pain, but after three days the
pain disappeared; 11 patients had acute hemorrhage and
eight had previously complained of hemorrhage. In these
eight patients, the major complaint at diagnosis was
abdominal pain in six and vomiting in two. Out of 19 patients
with gastric bleeding, 16 had anemia (hemoglobin levels
between 4.5 and 9.9 mg/dl), 11 needed blood transfusion,
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but no patient required endoscopic hemostasis. Peristaltic
contractions in the epigastric region associated with
fullness and vomiting were the major complaint of a
seven-year-old with pyloric stenosis. With regard to the
nutritional status at the time of diagnosis, 76.7% of the
patients were well-nourished (15th  85th percentiles),
11.6% showed weight deficit (percentile < 15) and 11.6%
were overweight (percentile > 85). Three of five patients
with weight deficit had ulcer complications.
Family history of peptic ulcer disease was observed in
24/42 (57.1%) patients, but one patient was excluded for
having been adopted. Duodenal ulcer was observed in
seven first-degree relatives and in three second-degree
relatives, gastric ulcer was detected in six first-degree
relatives and in four second-degree relatives, and was
undefined in four second-degree patients.
Helicobacter pylori
The bacterium was found in 41/43 patients (95.3%),
and the rapid urease test and histological examination were
positive in 85.4% (35/41). Histological examination alone
was positive in five patients, compared to one patient in the
rapid urease test. This patient had had a positive histological
examination before the treatment and had not been
previously treated with eradication therapy.
Histology
All 43 patients had active chronic gastritis. The intensity
of the neutrophil infiltrate was mild in 43%, moderate in
35% and intense in 22%. The histological analysis of the
gastric mucosa showed lymphoid follicles in 28% of the
patients, being associated with nodular lesions in the
gastric antrum in 31% of the cases.
Treatment for H. pylori infection
Helicobacter pylori was eradicated after antimicrobial
therapy in 68.3% of the patients (28/41), with different
therapeutic regimens. In 64.3% (18/28) the bacterium was
eradicated after the first antimicrobial treatment, in 14.3%
(4/28) after the second treatment and in 21.4% (6/28) after
the third treatment. When the bacterium was not eliminated,
antibiotics that had not been previously used or those which
did not result in bacterial resistance (nitroimidazole
derivatives) were chosen. Healing of the ulcer occurred in
100% of the patients in whom the bacterium was successfully
eradicated and in 89% of those in whom it was not
Discussion
The annual frequency of duodenal ulcer  (7.2 new cases
per year) was slightly higher than that described at other
referral centers (four to six cases/year), but similar to that
obtained in another center in Brazil, which reported 27
patients in four years, 6.75 patients a year.11 Recently, a
Russian study has surprisingly reported 31 adolescents in
one year, all of them with H. pylori-positive duodenal
ulcer.12 Roma et al., who reviewed the results of endoscopic
examinations of 2,550 chi ldren/nine years with
gastrointestinal symptoms, reported a 2% prevalence of
peptic ulcer, of which 81% was duodenal.13
Duodenal ulcer occurs at any age, but its frequency
increases after the tenth year of life, as observed in this
study.1 This age-related increase in incidence may be
related to the epidemiology of Helicobacter pylori infection,
whose prevalence increases with age in both industrialized
Symptom n %
Abdominal pain 39 90.7
Pain location*
Epigastric region 31 79.5
Periumbilical 7 17.9
Righ hypochondrium 1 2.6
Pain features*
Burning 22 56.4
Undefined 34 87.2
Night pain 27 69.2
Interference with patients 27 69.2
usual activities
Relationship with food intake*
Improved 20 51.3
Absent 19 48.7
Upper gastrointestinal bleeding 19 44.2
Other symptoms
Loss of appetite 32 74.4
Vomiting 30 69.8
Nauseas 29 67.4
Postprandial fullness 23 53.5
Weight loss 22 51.2
Anemia 21 48.8
Abdominal sensitivity 19 44.2
Table 1 - Clinical features of 43 patients with duodenal ulcer
* Among patients with abdominal pain (n = 39).
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The time between symptom onset and diagnosis was
longer in younger patients: in 10 patients with symptom
onset before the age of six years it was of 1 year and 4
months to 10 years and 6 months (median = 5 years); in
12 patients with symptom onset between 6 and 10 years
it was of 1 month to 5 years and 10 months (median = 2
years and 8 months) and in 21 patients with symptom
onset after the age of 10 years it was of 2 days to 2 years
and 7months (median = 1 year). The diagnosis was
established earlier when gastric bleeding was present.
The time interval between symptom onset and the
endoscopic examination in 12 patients with gastric bleeding
as major complaint ranged from 2 days to 2 months
(median = 6 days) whereas in 26 patients with abdominal
pain, it ranged from 9 months to 10 years (median = 2
years and 6 months).
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and developing countries.2 Late diagnosis occurred mainly
in younger children, as pointed out by other authors.14
Abdominal pain was the most frequent symptom,
corroborating the findings of other studies, and it affected
the epigastric region in most of the patients.11,12,14 Typical
characteristics of peptic ulcer disease, such as improvement
with the intake of some foods, albeit less frequent among
children, do occur and should be investigated.15 Abdominal
pain should be distinguished from functional abdominal
pain, much more prevalent among children, which may
interfere with usual activities, and the differential diagnosis
with organic disease based only on clinical criteria may be
a difficult task. Clinical data with a better discriminatory
power to differentiate between symptomatic children with
and without ulcer are: pain in the epigastric region,
relationship of pain to food intake, vomiting, night pain
(patient is awakened), bitter taste in the mouth, retrosternal
burning, upper gastrointestinal bleeding and family
history.12,16 Night pain, despite sensitive, is not so specific,
and if the high prevalence of functional abdominal pain is
taken into account, its positive predictive value is low.16,17
Family history of peptic ulcer has been reported in 26 to
68% of the cases, and is more frequent, the closer the
consanguineous relationship between family members.14,15
In the present study, we considered relatives up to the
second degree of consanguinity or affinity, and because of
that, our results might have been underestimated as only
cases with endoscopic diagnosis were registered. The
occurrence of family cases may result from the dissemination
of Helicobacter pylori in the household, since the history of
peptic ulcer disease among family members is more frequent
in infected patients. These observations may be explained
by the intrafamilial transmission of H. pylori, from a common
source or from person-to-person comtact.18
Complications of duodenal ulcer include upper
gastrointestinal bleeding, perforation and obstruction.15,19
Its relative frequency is higher among children, probably
due to late diagnosis.19 Diagnosis may be further delayed
when the major complaint is abdominal pain, compared with
hematemesis, as observed in this study. In patients in
whom abdominal pain is the major clinical symptom,
difficulties related to the characterization of pain and to the
high prevalence of functional abdominal pain may delay the
diagnosis. In our study, hemorrhage was the most frequently
reported ulcer complication, while in the literature, the
frequency of upper gastrointestinal bleeding ranges from 24
to 80%.1,20 Hematemesis as an isolated symptom without
abdominal pain occurred in 15.8% (3/19) of the patients,
but it may be present in up to 25% of the cases.21 Only one
patient had pyloric obstruction, whereas a study conducted
in southern India in 198322 reported 8/12 patients with
pyloric stenosis out of  29 patients with duodenal ulcer in 18
years, comparatively to much lower rates reported by other
authors.
In the present study, chronic gastritis associated with
Helicobacter pylori infection was observed in  most patients,
similarly to what occurred in other studies conducted in
different countries, in which this infection was detected in
up to 100% of patients with duodenal ulcer, although some
studies report rates as low as 27%.1,12,18,20,23 This difference
may be attributed to the focal distribution of the bacterium
and to the lower number of biopsy specimens collected.
Histological examination and the rapid urease test exhibit
good diagnostic accuracy, as observed in our setting, with
a sensitivity and specificity for the histological analysis of 92
and 100% and of 100 and 84.2% for the rapid urease test.8
The patient in whom only the urease test was positive had
had a positive histological examination before, in addition,
the biopsy revealed neutrophil infiltrate, a finding that
indicates high specificity for Helicobacter pylori infection, as
the bacterium may have a focal distribution.24
The presence of duodenal ulcer in infected patients is
mainly related to the occurrence of antral gastritis,1,20,24 as
observed in the present study. There has been predominance
of polymorphonuclear infiltrate in adult patients,25 whereas
in children, inflammatory infiltrate is usually more chronic,
with a significantly larger number of lymphoplasmacytic
cells than polymorphonuclear ones.21 However, histological
findings in infected children are not consistent, and seemingly
depend on socioeconomic conditions.26
The two uninfected patients had neutrophil infiltrate,
which indicates high specificity for Helicobacter pylori
infection, and perhaps, the bacterium has not been detected
because of the focal distribution of the infection.24 The use
of a noninvasive test, as the 13C urea breath test, could
complement the diagnosis, but unfortunately this test is not
available for routine use in our setting.27
The antimicrobial treatments used showed a low
eradication rate (68.3%). There is no therapeutic regime
that is 100% efficient; therefore, it is necessary to combine
antimicrobials taking into consideration regional factors,
such as bacterial resistance and level of adherence to
onerous medical treatments, with multiple drugs and side
effects. So, there is no therapeutic regimen universally
validated for children.28,29 Throughout the years, after
combining several antibiotics with antisecretory drugs or
bismuth salts, we obtained the best results with triple
therapy containing amoxicillin, clarithromycin and proton
pump inhibitor with an eradication rate of  73 and 50% in 10
and seven days of treatment, respectively,30 and more
recently, 88.9% in a preliminary intention-to-treat
assessment of 18 patients (unpublished data) with
furazolidone, clarithromycin and omeprazole for seven days.
In conclusion, duodenal ulcer was associated with chronic
gastritis and Helicobacter pylori infection in most children
and adolescents. Complications were highly frequent,
including especially upper gastrointestinal bleeding, and
late diagnosis occurred especially in younger children.
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